Groupe la Francaise’s Boston Scientific BSX Stock Holding History

Groupe la Francaise’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$21.9M	Sell	346,901 -178,527	-34%	-$14.3M	0.3%	68
2025 Q4	$49.9M	Sell	525,428 -90,225	-15%	-$8.85M	0.7%	33
2025 Q3	$60M	Sell	615,653 -16,478	-3%	-$1.71M	0.81%	28
2025 Q2	$67.9M	Buy	632,131 +297,049	+89%	+$30.1M	1.1%	23
2025 Q1	$33.6M	Buy	335,082 +38,701	+13%	+$3.9M	0.71%	37
2024 Q4	$25.9M	Buy	+296,381	New	+$26.1M	0.64%	35

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Groupe la Francaise's BSX Position: Q1 2026 in Review

Groupe la Francaise reduced its Boston Scientific (BSX) stake by 34% in Q1 2026, selling an estimated $14.3M and leaving 346,901 shares worth $21.9M. The position accounts for 0.3% of the portfolio, ranked #68.

Groupe la Francaise first reported a position in BSX in Q4 2024 and has held it in 6 quarters since. The position peaked at $67.9M in Q2 2025. 1,676 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

Groupe la Francaise held 346,901 shares of Boston Scientific worth $21.9M as of Q1 2026.
Groupe la Francaise sold 178,527 Boston Scientific shares in Q1 2026, an estimated $14.3M.
Boston Scientific made up 0.3% of Groupe la Francaise's portfolio in Q1 2026, its #68 holding.
Groupe la Francaise first reported a position in Boston Scientific in Q4 2024 and has held it in 6 quarters since.
Groupe la Francaise's Boston Scientific position peaked at $67.9M in Q2 2025.
1,676 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Groupe la Francaise's 13F filing for Q1 2026, filed 21 May 2026.